2
How to cite this paper
APA: Chaban, I., Chulovska, Z., Lelyukh, M., Chulovska, U & Chaban, T. (2026). Thiazole heterocycles as emerging anti-inflammatory agents: A strategic review. Current Chemistry Letters, 15(3), 627-646.
Chicago/Turabian: Chaban, I., Chulovska, Z., Lelyukh, M., Chulovska, U & Chaban, T. 2026. "Thiazole heterocycles as emerging anti-inflammatory agents: A strategic review." Current Chemistry Letters 15, no. 3 (2026): 627-646.
AMA: Chaban, I., Chulovska, Z., Lelyukh, M., Chulovska, U & Chaban, T. Thiazole heterocycles as emerging anti-inflammatory agents: A strategic review. Current Chemistry Letters. 2026;15(3):627-646.
References
1. Chavda V.P., Feehan J., Apostolopoulos V. (2024) Inflammation: The cause of all diseases. Cells, 13(22) 1906. https://doi.org/10.3390/cells13221906
2. Zhang W., Xiazo D., Mao Q., Xia H. (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target. Ther., 8 267. https://doi.org/10.1038/s41392-023-01486-5
3. Greten F.R., Grivennikov S.I. (2019) Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity, 51(1) 27-41. https://doi.org/10.1016/j.immuni.2019.06.025
4. Jones R., Rubin G., Berenbaum F., Schieman J. (2008) Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am. J. Med., 121(6) 464-474. https://doi.org/10.1016/j.amjmed.2008.01.045
5. Zhang X., Donnan P.T., Bell S., Guthrie B. (2017) Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol., 18 256. https://doi.org/10.1186/s12882-017-0673-8
6. Oray M., Samra K.A., Ebrahimiadib N., Meese H., Foster C.S. (2016) Long-term side effects of glucocorticoids. Expert Opin. Drug Saf., 15(4) 457-465. https://doi.org/10.1517/14740338.2016.1140743
7. Singh A., Malhotra D., Singh K., Chadha R., Mohinder P., Bedi S. (2022) Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes. J. Mol. Struct., 1266 133479. https://doi.org/10.1016/j.molstruc.2022.133479
8. Chhabria M.T., Patel S., Modi P., Brahmkshatriya P.S. (2016) Thiazole: A review on chemistry, synthesis and therapeutic importance of its derivatives. Curr. Top. Med. Chem., 16(26) 2841-2862. https://doi.org/10.2174/1568026616666160506130731
9. Drapak I., Chaban, T., FoliushV., Matiychuk V. (2020) Synthesis antimicrobial and antitumor activities of 2-[5-(2-R-benzyl) thiazol-2-ylimino] thiazolidin-4-ones. Biointerface Res. Appl. Chem., 10(3), 5507-5511. https://doi.org/10.33263/BRIAC103.507511
10. Maruthi T., Akash R.B., Yallur B.C., Manjunatha D.H. (2025) Thiazoles: Synthesis, biological activities and their interaction studies with serum albumins. Total Chem., 1 100006. https://doi.org/10.1016/j.totche.2025.100006
11. Tratrat C., Haroun M., Tsolaki E., Petrou A., Gavalas A., Geronikaki A. (2021) Thiazole-based chalcone derivatives as potential anti-inflammatory agents: Biological evaluation and molecular modelling. Curr. Top. Med. Chem., 21(4) 257-268. https://doi.org/10.2174/1568026621999201214232458
12. Rydchuk P., Tymoshuk O., Oleksiv L., Chaban T., Matiychuk V. (2019) Voltammetric determination of Pt (IV) using 5-hydroxyimino-4-imino-1,3-thiazolidine-2-one. Methods Objects Chem. Anal., 14(3) 130-139. http://dx.doi.org/10.17721/moca.2019.130-139
13. Bhagwat S.K., Chobe S.S., Alavala R.R., Vora A., More R.A., Bobade V.D., Patil A.A., Pawar T.J., Hernández-Rosas F., Patil S.V. (2025) Benzothiazole-thiazole hybrids as broad-spectrum antimicrobial agents: synthesis, SAR analysis, and molecular docking against bacterial and fungal targets. RSC Adv., 15 31752-31762. https://doi.org/10.1039/D5RA04254B
14. Niu Z.-X., Wang Y.-T., Zhang S.-N., Li Y., Chen X.-B., Wang S.-Q., Liu H.-M. (2023) Application and synthesis of thiazole ring in clinically approved drugs. Eur. J. Med. Chem., 250 115172. https://doi.org/10.1016/j.ejmech.2023.115172
15. Chaban T.I., Matiichuk Y.E., Horishny V.Y., Chaban I.G., Matiychuk V.S. (2020) Synthesis and anticancer activity of 2-aryl-3-methylbenzofuro[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-dione and 2-aryl-3,7,9-trimethylpyrido[3',2':4,5]thieno[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-diones. Russ. J. Org. Chem., 56(5), 813-818. http://dx.doi.org/10.1134/S1070428020050139
16. Chugh V., Pandey G., Rautela R., Mohan C. (2022) Heterocyclic compounds containing thiazole ring as important material in medicinal chemistry. Mater. Today Proc., 69(2) 478-481. https://doi.org/10.1016/j.matpr.2022.09.150
17. Meanwell N.A. (2011) Synopsis of some recent tactical application of bioisosteres in drug design. J. Med. Chem., 54(8) 2529-2591. https://doi.org/10.1021/jm1013693
18. Brown D.G., Boström J. (2016) Analysis of past and present synthetic methodologies on medicinal chemistry: Where have all the new reactions gone? J. Med. Chem., 59(10) 4443-4458. https://doi.org/10.1021/acs.jmedchem.5b01409
19. Petrou A., Fesatidou M., Geronikaki A. (2021) Thiazole ring – A biologically active scaffold. Molesules, 26(11) 3166. https://doi.org/10.3390/molecules26113166
20. Gümüş M., Yakan M., Koca I. (2019) Recent advances of thiazole hybrids in biological applications. Future Med. Chem., 11(15) 1979-1998. https://doi.org/10.4155/fmc-2018-0196
21. Shahin I.G., Mohamed K.O., Taher A.T., Mayhoub A.S., Kassab A.E. (2023) Recent advances in the synthesis of thiazole ring: Mini review. Mini-Rev. Org. Chem., 20(3) 270-284. https://doi.org/10.2174/1570193X19666220413104255
22. Lelyukh M., Adamchuk S., Harkov S., Chaban I., Demchuk I., Shelepeten L., Chaban T. (2018) Synthetic approaches, chemical modification and biological activity of non-condensed 1,3,4-thiadiazole derivatives: A review. Pharmacia, 65(4) 72-88.
23. Minakshi, Kaswan P., Singh K., Devi, Singh R., Yadav N., Yadav M. (2025) Recent advances in di-, tri-substituted mono-thiazoles, and bis-thiazoles: Factors affecting biological activities, future aspects, and challenges. Curr. Top. Med. Chem., 25(23) 2681-2726. 10.2174/0115680266334873250316102556
24. Narasimhamurthy K.H., Swaroop T.R., Rangappa K.S. (2024) A review on progress of thiazole derivatives as potential anti-inflammatory agents. Reports, 12 100225. https://doi.org/10.1016/j.ejmcr.2024.100225
25. Klebe G. (2015) Applying thermodynamic profiling in lead finding and optimization. Nat. Rev. Drug Discov., 14 95-110. https://doi.org/10.1038/nrd4486
26. El-Shoukrofy M.S., Ismail A., Elhamammy R.H., Abdelhady S.A., Nassra R., Makkar M.S., Agami M.A., Wahid A., Nematalla H.A., Sai M., Merk D., El-Yazbi A.F., Belal A.S.F., Eid A.H., Elzahhar P.A. (2025) Novel thiazolones for the simultaneous modulation of PPARγ, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation. Eur. J. Med. Chem., 289 117415. https://doi.org/10.1016/j.ejmech.2025.117415
27. Jacob J.P., Manju S.L. (2020) Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity. Bioorg. Chem., 100 103882. https://doi.org/10.1016/j.bioorg.2020.103882
28. Sinha S., Manju S.L., Doble M (2019) Chalcone-thiazole hybrids: Rational design, synthesis, and lead identification against 5-lipoxygenase. ACS Med. Chem., 10(10) 1415-1422. https://doi.org/10.1021/acsmedchemlett.9b00193
29. Hawash M., Jaradat N., Sabobeh R., Abualhasan M., Qaoud M.T. (2023) New thiazole carboxamide derivatives as COX inhibitors: Design, synthesis, anticancer screening, in silico molecular docking, and ADME profile studies. ACS Omega, 8(32) 29512-29526. https://doi.org/10.1021/acsomega.3c03256
30. Minhas R., Bansal Y., Bansal G. (2019) Inducible nitric oxide synthase inhibitors: A comprehensive update. Med. Res. Rev., 40(3) 823-855. https://doi.org/10.1002/med.21636
31. Seboletswe P., Cele N., Singh P. (2023) Thiazolidinone-heterocycle frameworks: A concise review of their pharmacological significance. ChemMedChem., 18(7) e20220618. https://doi.org/10.1002/cmdc.202200618
32. Сhulovska Z, Chaban T., Drapak I., Matiychuk V. Chaban I., Nektegaev I. (2021) Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents. Biointerface Res. Appl. Chem., 11(1) 8009-8017. https://doi.org/10.33263/BRIAC111.80098017
33. Singh V., Jha K.T., Singh S., Singh R., Chawla P.A. (2025) Targeting inflammation through inhibition of COX-2 by substituted 4-thiazolidinone analogues: in-vitro, in-vivo and in-silico studies. J. Mol. Struct., 1319(1) 139393. https://doi.org/10.1016/j.molstruc.2024.139393
34. Mekhlef Y.O., AboulMagd A.M., Gouda A.M. (2023) Design, synthesis, molecular docking, and biological evaluation of novel 2,3-diaryl-1,3-thiazolidine-4-one derivatives as potential anti-inflammatory and cytotoxic agents. Bioorg. Chem., 133 106411. https://doi.org/10.1016/j.bioorg.2023.106411
35. Archna, Chawla P.A., Teli G., Pathania S., Singh S., Srivastava V. (2023) Exploration of antioxidant, anti-inflammatory and anticancer potential of substituted 4-thiazolidinone derivatives: Synthesis, biological evaluation and docking studies. Polycycl. Aromat. Compd., 43(1) 597-618. https://doi.org/10.1080/10406638.2021.2019796
36. Omar Y.M., Abdel-Moty S.G., Abdu-Allah H.H.M. (2020) Further insight into the dual COX-2 and 15-LOX anti-inlammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent. Bioorg. Chem., 97 103657. https://doi.org/10.1016/j.bioorg.2020.103657
37. Liaras K., Fesatidou M., Geronikaki A. (2018) Thiazoles and thiazolidinones as COX/LOX inhibitors. Molecules, 23(3) 685. https://doi.org/10.3390/molecules23030685
38. Mech D., Kurowska A., Trotsko N. (2021) The bioactivity of thiazolidin-4-ones: A short review of the most recent studies. Int. J. Mol. Sci., 22(21) 11533. https://doi.org/10.3390/ijms222111533
39. Yadav K.P., Rahman MdA., Nishad S., Maurya S.K., Anas M., Mujahid M. (2023) Synthesis and biological activities of benzothiazole derivatives: A review. Intell. Pharm., 1(3) 122-132. https://doi.org/10.1016/j.ipha.2023.06.001
40. Islam MdR., Fahmy H. (2022) Thiazolopyrimidine scaffold as a promising nucleus for developing anticancer drugs: A review conducted in last decade. Anticancer Agents Med. Chem., 22(17) 2942-2955. https://doi.org/10.2174/1871520622666220411110528
41. Amrutkar V.S., Khator R., Monga V (2025) Recent progress in the synthetic and medicinal perspective of imidazo[2,1-b]thiazole derivatives. Future Med. Chem., 17(17) 2163-2177. https://doi.org/10.1080/17568919.2025.2552637
42. Keri R.S., Patil M.R., Patil S.A., Budagumpi S. (2015) A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. Eur. J. Med. Chem., 89 207-251. https://doi.org/10.3897/10.1016/j.ejmech.2014.10.059
43. Mishra S., Arora N., Gupta S.K., Yogi B., Arora P. (2025) Recent advances in pyrazole and benzothiazole derivatives as potential anti-inflammatory agents: Synthesis, mechanisms, and therapeutic implication. Chem. Res. J., 10(3) 69-77.
44. Tan J., He Y., Lin U., Zhong Y., He S., Zuo J., Yang C. (2024) Synthesis of 2-amino-9H-chromeno[2,3-d]thiazol-9-ones with anti-inflammatory activity via cascade reactions of 2-amino-3 iodochromones with amines and carbon disulfide. RSC Adv., 14 3158-3162. https://doi.org/10.1039/D3RA07209F
45. Gupta K., Sirbaiya A.K., Kumar V., Rahman M.A. (2022) Current perspective of synthesis of medicinally relevant benzothiazole based molecules: Potential for antimicrobial and anti-inflammatory activities. Mini-Rev. Med. Chem., 22(14) 1895-1935. https://doi.org/10.2174/1389557522666220217101805
46. Chaban T., Matiychuk V., Komarytsya O., Myrko I., Chaban I., Ogurtsov V., Nektegaev I. (2020) Anti-inflammatory properties of some novel thiazolo[4,5-b]pyridin-2-ones. Pharmacia, 67(3) 121-127. https://doi.org/10.3897/pharmacia.67.e38969
47. Shahrasbi M., Mohaved M.A., Dadras O.G., Daraei B., Zarghi A. (2018) Design, synthesis and biological evaluation of new imidazo[2,1-b]thiazole derivatives as selective COX-2 inhibitors. Iran. J. Pharm. Res., 17(4) 1288-1296.
48. Bhagwat S.K., Chobe S.S., Alavala R.R., Vora A., More R.A., Bobade V.D., Patil A.A., Pawar T.J., Hernandez-Rosas F., Patil S.V. (2025) Benzothiazole–thiazole hybrids as broad-spectrum antimicrobial agents: Synthesis, SAR analysis, and molecular docking against bacterial and fungal targets. RSC Adv., 15 31752-31762. https://doi.org/10.1039/D5RA04254B
49. Alkorbi F., Alshareef S.A., Abdelaziz M.A., Omer N., Jame R., Alatawi I.S., Ali A.M., Omran O.A., Bakr R.B. (2025) Multicomponent reaction for synthesis, molecular docking, and anti-inflammatory evaluation of novel indole-thiazole hybrid derivatives. Mol. Divers., 29(5) 3945-3956. https://doi.org/10.1007/s11030-024-10969-8
50. Abdul-Malik M.A., El-Dean A.M.K., Hussein A.H.M., Abdelmonsef A.H., Tolba M.S. (2026) Synthesis, in silico and in vivo evaluation of new pyrazole-based thiosemicarbazones containing thiazole and thiazolone moieties as potential anti-inflammatory agents. J. Mol. Struct., 1350(1) 143990. https://doi.org/10.1016/j.molstruc.2025.143990
51. Ungureanu D., Marc G., Tiperciuc B., Moldovan C., Ionut I., Staba A., Oniga I., Vlase L., Pîrnău A., Oniga O. (2025) Novel 3,4-dihydroxyphenyl-thiazole-coumarin hybrid compounds: Synthesis, in silico and in vitro evaluation of their antioxidant activity. Antioxidants, 14(6) 636. https://doi.org/10.3390/antiox14060636
52. Cancela S., Minini L., Mourglia-Ettlin G., Merlino A., Lavaggi M.L., Hernandez P. (2025) Novel thiazole-nitrone hybrids as innovative neuroprotective agents with antioxidant and antiapoptotic properties. Results Chem., 16 102414. https://doi.org/10.1016/j.rechem.2025.102414
53. Hegazy M.E., Taher E.S., Ghiaty A.H., Bayoumi A.H. (2024) Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study. Biorg. Chem., 145 107244. https://doi.org/10.1016/j.bioorg.2024.107244
54. Maghraby M.T.-E., Abou-Ghadir O.M.F., Abdel-Moty S.G., Ali A.Y., Salem O.I.A. (2020) Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes. Bioorg. Med. Chem., 28(7) 115403. https://doi.org/10.1016/j.bmc.2020.115403
55. Di L., Kerns E.H. (2003) Profiling drug-like properties in discovery research. Curr. Opin. Chem. Biol., 7(3) 402-408. https://doi.org/10.1016/S1367-5931(03)00055-3
56. Khanapure S.P., Garvey D.S., Janero D.R., Letts L.G. (2007) Eicosanoids in inflammation: Biosynthesis, pharmacology, and therapeutic frontiers. Curr. Top. Med. Chem., 7(3) 311-340. https://doi.org/10.2174/156802607779941314
57. Hawash M., Jaradat N., Abualhasan M., Şüküroğlu M.K., Qaoud M.T., Kahraman D.C., Daraghmeh H., Maslamani L., Sawafta M., Ratrout A., Issa L. (2023) Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors. BMC Chem., 17(1) 11. https://doi.org/10.1186/s13065-023-00924-3
58. Mohammed E.R., Abd-El-Fatah A.H., Mohamed A.R., Mahrouse M.A., Mohammad M.A. (2024) Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations. Bioorg. Chem., 147 107372. https://doi.org/10.1016/j.bioorg.2024.107372
59. Sinha S., Sravanthi T.V., Yuvaraj S., Manju S.L., Doble M. (2016) 2-Amino-4-aryl thiazole: A promising scaffold identified as a potent 5-LOX inhibitor. RSC Adv., 6(13) 19271-19279. https://doi.org/10.1039/C5RA28187C
60. Agrawal N. (2025) A comprehensive review on the advancements of dual COX-2/5-LOX inhibitors as anti-inflammatory drugs. Chem. Biol. Drug. Des., 105(5) e70114. https://doi.org/10.1111/cbdd.70114
61. Abdulaziz O., Alsuwat M.A., Jan M.S., Sadiq A. (2024) Modification of 4-(4-chlorothiophen-2-yl)thiazol-2-amine derivatives for the treatment of analgesia and inflammation: Synthesis and in vitro, in vivo, and in silico studies. Front. Pharmacol., 15 1366695. https://doi.org/10.3389/fphar.2024.1366695
62. Vasu K.K., Digwal C.S., Pandya A.N., Pandya D.H., Sharma J.A., Patel S., Agarwal M. (2017) Imidazo[1,2-a]pyridines linked with thiazoles/thiophene motif through keto spacer as potential cytotoxic agents and NF-κB inhibitors. Bioorg. Med. Chem. Lett., 27(24) 5463-5466. https://doi.org/10.1016/j.bmcl.2017.10.060
63. Üremiş M.M., Üremiş N., Ceylan M., Türköz Y. (2025) Anticancer and anti-inflammatory effects of benzothiazole derivatives targeting NF-κB/COX-2/iNOS in a hepatocellular carcinoma cell line. Turk. J. Pharm. Sci., 22(3) 207-216. https://doi.org/10.4274/tjps.galenos.2025.49840
64. Tariq S., Alam O., Amir M. (2018) Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1,2,4-triazole-based benzothiazole-2-amines. Arch. Pharm., 351(3-4) 1700304. https://doi.org/10.1002/ardp.201700304
65. Ebaid M.S., Ibrahim H.A.A., Kassem A.F., Sabt A. (2024) Recent studies on protein kinase signaling inhibitors based on thiazoles: Review to date. RSC Adv., 14(50) 36989-37018. https://doi.org/10.1039/d4ra05601a
66. Ge L., Hu Q., Shi M., Yang H., Zhu G. (2017) Design and discovery of novel thiazole derivatives as potential MMP inhibitors to protect against acute lung injury in sepsis rats via attenuation of inflammation and apoptotic oxidative stress. RSC Adv., 7 32909-32922. https://doi.org/10.1039/C7RA03511J
67. Malik Z., Abbas M., Al Kury L.T., Shah F.A., Alam M., Khan A.-U., Nadeem H., Alghamdi S., Sahibzada M.U.K., Li S. (2021) Thiazolidine derivatives attenuate carrageenan-induced inflammatory pain in mice. Drug Des. Devel. Ther., 15 369-384. https://doi.org/10.2147/DDDT.S281559
68. Sung M., Lim S., Park S., Choi Y., Kom S. (2024) Anti-inflammatory effects of phytosphingosine-regulated cytokines and NF-kB and MAPK mechanism. Cell. Mol. Biol., 70(9) 22-30. https://doi.org/10.14715/cmb/2024.70.9.3
69. Filho C.A.L.M., de Oliveira Barbosa M., Oliveira A.R., Pinto A.F., Araújo D.L., Lucena J.P., de Araújo R.E., de Oliveira S.A., Leite A.C.L. (2022) The prophylactic and anti-fibrotic activity of phthalimido-thiazole derivatives in schistosomiasis mansoni. Parasitol Res., 121(7) 2111-2120. https://doi.org/10.1007/s00436-022-07533-4
70. Feng X., Yu W., Cao L., Meng F., Cong M. (2020) A novel chrysin thiazole derivative polarizes macrophages to an M1 phenotype via targeting TLR4. Int. Immunopharmacol., 88 106986. https://doi.org/10.1016/j.intimp.2020.106986
71. Manful C.F., Fordjour E., Ikumoinein E., Abbey L., Thomas R. (2025) Therapeutic strategies targeting oxidative stress and inflammation: A narrative review. BioChem., 5(4) 35. https://doi.org/10.3390/biochem5040035
72. Marc G., Stana A., Franchini A.H., Vodnar D.C., Barta G., Tertis M., Santa I., Cristea C., Pîrnău A., Ciorîţă A., Dume B., Toma V.-A., Vlase L., Oniga I., Oniga O. (2021) Phenolic thiazoles with antioxidant and antiradical activity. Synthesis, in vitro evaluation, toxicity, electrochemical behavior, quantum studies and antimicrobial screening. Antioxidants, 10(11) 1707. https://doi.org/10.3390/antiox10111707
73. Shalai Ya.R., Popovych M.V., Mandzynets S.M., Hreniukh V.P., Finiuk N.S., Babsky A.M. (2021) Prooxidant and antioxidant processes in the liver homogenate of healthy and tumor-bearing mice under the action of thiazole derivatives. Ukr. Biochem. J., 93(3) 61-67. doi: https://doi.org/10.15407/ubj93.03.061
74. Korkmaz I.N. (2024) Investigation of the effects of thiazole compounds on thioredoxin reductase 1 (TrxR1), glutathione S-transferase (GST), and glutathione reductase (GR) targeted human brain glioblastoma cancer (U-87 MG). Biotechnol. Appl. Biochem., 71(4) 948-959. https://doi.org/10.1002/bab.2589
75. Zhong R., Miao L., Zhang H., Tan L., Zhao Y., Tu Y., Prieto A., Simal-Gandara J., Chen L., He C., Cao H. (2022) Anti-inflammatory activity of flavonols via inhibiting MAPK and NF-κB signaling pathways in RAW264.7 macrophages. Curr. Res. Food Sci., 5 1176-1184. https://doi.org/10.1016/j.crfs.2022.07.007
76. Raut D.G., Bhosale R.B., Lawand A.S., Hublikar M.G., Kadu V.D., Patil S.B., Choudhari P.B. (2022) Syntheses, molecular docking and biological evaluation of 2-(2-hydrazinyl)thiazoles as potential antioxidant, anti-inflammatory and significant anticancer agents. Recent Pat. Inflamm. Allergy. Drug Discov., 16(2) 96-106. https://doi.org/10.2174/2772270816666220902094019
77. Smelcerovic A., Zivkovic A., Ilic B.S., Kolarevic A., Hofmann B., Steinhilber D., Stark H. (2020) 4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibition. Bioorg. Chem., 95 103528. https://doi.org/10.1016/j.bioorg.2019.103528
78. Sağlık B.N., Osmaniye D., Levent S., Çevik U.A., Çavuşoğlu B.K., Yusuf Özkay Y., Kaplancikli Z.A. (2021) Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety. Eur. J. Med. Chem., 209 112918. https://doi.org/10.1016/j.ejmech.2020.112918
79. Fadaly W.A.A., Zidan T.H., Kahk N.M., Mohamed F.E.A., Abdelhakeem M.M., Khalil R.G., Nemr M..M. (2023) New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: Design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies. J. Enzyme Inhib. Med. Chem., 38(1) 2281262. https://doi.org/10.1080/14756366.2023.2281262
80. Irmak N.E., Saglik B.N., Celik I., Sen H.T., Ozkay Y., Ayhan-Kilcigil G. (2023) Design, synthesis, molecular docking and molecular dynamic studies of novel benzimidazole–thiazole derivatives as potent and selective COX-2 inhibitors. New J. Chem., 47 21620-21632. https://doi.org/10.1039/D3NJ04438F
81. Jaismy J.P., Manju S.L. (2021) Novel approach of multi-targeted thiazoles and thiazolidenes toward anti-inflammatory and anticancer therapy – dual inhibition of COX-2 and 5-LOX enzymes. Med. Chem. Res., 30 236-257. https://doi.org/10.1007/s00044-020-02655-9
82. Elgohary M.K., Abd El Hadi S.R., Abo-Ashour M.F., Abo-El Fetoh M.E., Afify H., Abdel-Aziz H.A., Abou-Seri S.M. (2023) Fragment merging approach for the design of thiazole/thiazolidine clubbed pyrazoline derivatives as anti-inflammatory agents: Synthesis, biopharmacological evaluation and molecular modeling studies. Bioorg. Chem., 139 106724. https://doi.org/10.1016/j.bioorg.2023.106724
83. El-Miligy M.M.M., Al-Kubeisi A.K., Nassra R.A., El-Zemity S.R., Hazzaa A.A. (2024) Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof. J. Enzyme Inhib. Med. Chem., 39(1) 2309171. https://doi.org/10.1080/14756366.2024.2309171
84. Kim M.E., Le J.S. (2025) Advances in the regulation of inflammatory mediators in nitric oxide synthase: Implications for disease modulation and therapeutic approaches. Int. J. Mol. Sci., 26(3) 1204. https://doi.org/10.3390/ijms26031204
85. Khanh N.D., Anh N.T.H., Son N.V., Tho N.T.M., Yhang N.T.N., Quyen T.T., An T.N.M. (2026) Design, synthesis, biological evaluation, and in silico studies of novel 1,3-thiazole derivatives. RSC Adv., 16 2342. https://doi.org/10.1039/D5RA08472E
86. Fang S., Huang X., Cai F., Qiu G., Lin F., Cai X. (2024) Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells. J. Steroid Biochem. Mol. Biol., 240 106478. https://doi.org/10.1016/j.jsbmb.2024.106478
87. Facchin B.M., Dos Reis G.O., Vieira G.N., Mohr E.T.B., da Rosa J.S., Kretzer I.F., Demarchi I.G., Dalmarco E.M. (2022) Inflammatory biomarkers on an LPS-induced RAW 264.7 cell model: A systematic review and meta-analysis. Inflamm. Res., 71(7-8) 741-758. https://doi.org/10.1007/s00011-022-01584-0
88. Ganie M.A., Ansari S.M., Choudhary R., Fayaz F., Kour G., Gupta V., Ahmed Z., Javed S., Shah B.A. (2024) Investigation of an aminothiazole-based scaffold as an anti-inflammatory agent: Potential application in the management of cytokine storm in SARS-CoV-19. J. Mol. Struct., 1303 137562. https://doi.org/10.1016/j.molstruc.2024.137562
89. Efeoglu C., Taskin S., Selcuk O., Celik B., Tumkaya E., Ece A., Sari H., Seferoglu Z., Ayaz F., Nural Y. (2023) Synthesis, anti-inflammatory activity, inverse molecular docking, and acid dissociation constants of new naphthoquinone-thiazole hybrids. Bioorg. Med. Chem., 95 117510. https://doi.org/10.1016/j.bmc.2023.117510
90. Xu X., Zhu Z., Chen S., Fu Y., Zhang J., Guo Y., Xu Z., Xi Y., Wang X., Ye F., Chen H., and Yang X. (2024) Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents. Front. Chem., 12 1384301. https://doi.org/10.3389/fchem.2024.1384301
91. Fang T., Eglen R.M. (2017) Three-dimensional cell cultures in drug discovery and development. SLAS Discov., 22(5) 456-472. https://doi.org/10.1177/1087057117696795
92. Rumpf J., Burger R., Schulze M. (2023) Statistical evaluation of DPPH, ABTS, FRAP, and Folin-Ciocalteu assays to assess the antioxidant capacity of lignins. Int. J. Biol. Macromol., 233 123470. https://doi.org/10.1016/j.ijbiomac.2023.123470
93. Bansal A., Bali A., Balaini A. (2020) Synthesis and evaluation of substituted aryl thiazoles with antioxidant potential as gastro-sparing anti-inflammatory agents. Lett. Drug Des. Discov., 17(12) 1566-1578. https://doi.org/10.2174/1570180817999200706005247
94. Patil S.M., Kamble O., Asgaonkar K., Bhandari S., Chitre T., Rathod V., Bhosale P., Gavali P., Das A. (2026) Design and development of pyrazole–thiazole hybrid derivatives as anti-inflammatory and anti-oxidant agents. J. Mol. Struct., 1353(2) 144688. https://doi.org/10.1016/j.molstruc.2025.144688
95. Eruslanov E., Kusmartsev S. (2010) Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol., 594 57-72. https://doi.org/10.1007/978-1-60761-411-1_4
96. Leng S.X., McElhaney J.E., Walston J.D., Xie D., Fedarko N.S., Kuchel G.A. (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A Biol. Sci. Med. Sci., 63(8) 879-884. https://doi.org/10.1093/gerona/63.8.879
97. Liou C.-J., Len W.-B., Wu S.-J., Lin C.-F., Wu X.-L., Huang W.-C. (2014) Casticin inhibits COX-2 and iNOS expression via suppression of NF-κB and MAPK signaling in lipopolysaccharide-stimulated mouse macrophages. J. Ethnopharmacol., 158 310-316. https://doi.org/10.1016/j.jep.2014.10.046
98. Yan Z., Wang Y., Song Y., Ma Y., An Y., Wen R., Wang N., Huang Y., Wu X. (2023) Phenethylferulate as a natural inhibitor of inflammation in LPS-stimulated RAW 264.7 macrophages: Focus on NF-κB, Akt and MAPK signaling pathways. BMC Complement Med. Ther., 23 398. https://doi.org/10.1186/s12906-023-04234-y
99. Yue L., Luo J., Zhao C., Zhao J., Ye J., He K., Zou J. (2024) Oleanane triterpenoids with C-14 carboxyl group from Astilbe grandis inhibited LPS-induced macrophages activation by suppressing the NF-κB signaling pathway. Front. Pharmacol., 15 1413876. https://doi.org/10.3389/fphar.2024.1413876
100. Dahlin J.L., Walters M.A. (2014) The essential roles of chemistry in high-throughput screening triage. Future Med. Chem., 6(11) 1265-1290. https://doi.org/10.4155/fmc.14.60
101. Zhang Z., Cao P., Fang M., Zou T., Han J., Duan Y., Xu H., Yang X., Li Q.-S. (2021) Design, synthesis, and SAR study of novel 4,5-dihydropyrazole-thiazole derivatives with anti-inflammatory activities for the treatment of sepsis. Eur. J. Med. Chem., 225 113743. https://doi.org/10.1016/j.ejmech.2021.113743
102. Raut D.G., Lawand A.S., Kadu V.D., Hublikar M.G., Patil S.B., Bhosale D.G., Bhosale R.B. (2022) Synthesis of asymmetric thiazolyl pyrazolines as a potential antioxidant and anti-inflammatory agents. Polycycl. Aromat. Compd., 42(1) 70-79. https://doi.org/10.1080/10406638.2020.1716028
103. Hussain F., Tahir A., Rehman H.M., Wu Y., Shah M., Rashid U. (2025) Promising thiazolidinedione-thiazole based multi-target and neuroprotective hybrids for Alzheimer's disease: Design, synthesis, in-vitro, in-vivo and in-silico studies. Eur. J. Med. Chem., 287 117327. https://doi.org/10.1016/j.ejmech.2025.117327
104. Stella V.J., Nti-Addae K.W. (2007) Prodrug strategies to overcome poor water solubility. Adv. Drug Deliv. Rev., 59(7) 677-694. https://doi.org/10.1016/j.addr.2007.05.013
105. Lillethorup I.A., Hemmingsen A.V., Qvortrup K. (2025) Prodrugs and their activation mechanisms for brain drug delivery. RSC Med. Chem., 16 1037-1048. https://doi.org/10.1039/D4MD00788C
106. Islam S., Ahmed MdM.S., Islam M.A., Hossain N., Chowdhury M.A. (2025) Advances in nanoparticles in targeted drug delivery – A review. Results Surf. Interfaces, 19 100529. https://doi.org/10.1016/j.rsurfi.2025.100529
107. Hegde M., Mishra A., Banerjee R., Bintee B., Alqahtani M.S., Abbas M., Shanmugam M.K., Drum C.L., Setgi G., Liu L., Kunnumakkara A.B. (2025) Bioresponsive engineered nanoparticles for immunomodulation. BMC Med, 23 595. https://doi.org/10.1186/s12916-025-04305-6
108. Kumar G., Singh N.P. (2021) Synthesis, anti-inflammatory and analgesic evaluation of thiazole/oxazole substituted benzothiazole derivatives. Bioorg. Chem., 107 104608. https://doi.org/10.1016/j.bioorg.2020.104608
109. Abdel-Aziz S.A., Taher E.S., Lan P., El-Koussi N.A., Salem O.I.A., Gomaa H.A.M., Youssif B.G.M. (2022) New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition. Arch. Pharm., 355(7) 2200024. https://doi.org/10.1002/ardp.202200024
110. Khan S., Chinnam S., Iqbal T., Hussain R., Ur Rehman M., Khan Y., Iqbal J., Dera A.A. (2025) A novel class of thiazole based thiadiazole hybrids: The privileged scaffolds of potent anti-Alzheimer's activity along with molecular docking and ADME analysis. J. Mol. Struct., 1321(1) 139775. https://doi.org/10.1016/j.molstruc.2024.139775
111. Cai X., Cai J., Fang L., Xu S., Zhu H., Wu S., Chen Y., Fang S. (2024) Design, synthesis and molecular modeling of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazolinone derivatives as anti-inflammatory agents by inhibition of COX-2/iNOS production and down-regulation of NF-κB/MAPKs in LPS-induced RAW264.7 macrophage cells. Eur. J. Med. Chem., 272 116460. https://doi.org/10.1016/j.ejmech.2024.116460
112. Cai N., Gao X., Yang L., Li W., Sun W., Zhang S., Zhao J., Qu J., Zhou Y. (2024) Discovery of novel NSAID hybrids as cPLA2/COX-2 dual inhibitors alleviating rheumatoid arthritis via inhibiting p38 MAPK pathway. Eur. J. Med. Chem., 267 116176. https://doi.org/10.1016/j.ejmech.2024.116176
113. Kumari L., Choudhari Y., Patel P., Gupta G.D., Singh D., Rosenholm J.M., Bansal K.K., Kurmi B.D. (2023) Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs. Life, 13(5) 1099. https://doi.org/10.3390/life13051099
114. Du J., Li X., Zhao H., Zhou Y., Wang L., Tian S., Wang Y. (2015) Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies. Int. J. Pharm., 495(2) 738-749. https://doi.org/10.1016/j.ijpharm.2015.09.021
115. Arnott J.A., Planey S.L. (2012) The influence of lipophilicity in drug discovery and design. Expert Opin. Drug Discov., 7(10) 863-875. https://doi.org/10.1517/17460441.2012.714363
116. Gajula S.N.R., Nadimpalli N., Sonti R. (2021) Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug Metab. Rev., 53(3) 459-477. https://doi.org/10.1080/03602532.2021.1970178
117. Meanwell N.A. (2014) The influence of bioisosteres in drug design: Tactical applications to address developability problems. Tactics Contemp. Drug Des., 9 283-381. https://doi.org/10.1007/7355_2013_29
118. Bukke S.P.N., Venkatesh C., Rajanna S.B., Saraswathi T.S., Kusuma P.K., Goruntla N., Balasuramanyam N., Munishamireddy S. (2024) Solid lipid nanocarriers for drug delivery: design innovations and characterization strategies – a comprehensive review. Discov. Appl. Sci., 6 279. https://doi.org/10.1007/s42452-024-05897-z
2. Zhang W., Xiazo D., Mao Q., Xia H. (2023) Role of neuroinflammation in neurodegeneration development. Signal Transduct. Target. Ther., 8 267. https://doi.org/10.1038/s41392-023-01486-5
3. Greten F.R., Grivennikov S.I. (2019) Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity, 51(1) 27-41. https://doi.org/10.1016/j.immuni.2019.06.025
4. Jones R., Rubin G., Berenbaum F., Schieman J. (2008) Gastrointestinal and cardiovascular risks of nonsteroidal anti-inflammatory drugs. Am. J. Med., 121(6) 464-474. https://doi.org/10.1016/j.amjmed.2008.01.045
5. Zhang X., Donnan P.T., Bell S., Guthrie B. (2017) Non-steroidal anti-inflammatory drug induced acute kidney injury in the community dwelling general population and people with chronic kidney disease: systematic review and meta-analysis. BMC Nephrol., 18 256. https://doi.org/10.1186/s12882-017-0673-8
6. Oray M., Samra K.A., Ebrahimiadib N., Meese H., Foster C.S. (2016) Long-term side effects of glucocorticoids. Expert Opin. Drug Saf., 15(4) 457-465. https://doi.org/10.1517/14740338.2016.1140743
7. Singh A., Malhotra D., Singh K., Chadha R., Mohinder P., Bedi S. (2022) Thiazole derivatives in medicinal chemistry: Recent advancements in synthetic strategies, structure activity relationship and pharmacological outcomes. J. Mol. Struct., 1266 133479. https://doi.org/10.1016/j.molstruc.2022.133479
8. Chhabria M.T., Patel S., Modi P., Brahmkshatriya P.S. (2016) Thiazole: A review on chemistry, synthesis and therapeutic importance of its derivatives. Curr. Top. Med. Chem., 16(26) 2841-2862. https://doi.org/10.2174/1568026616666160506130731
9. Drapak I., Chaban, T., FoliushV., Matiychuk V. (2020) Synthesis antimicrobial and antitumor activities of 2-[5-(2-R-benzyl) thiazol-2-ylimino] thiazolidin-4-ones. Biointerface Res. Appl. Chem., 10(3), 5507-5511. https://doi.org/10.33263/BRIAC103.507511
10. Maruthi T., Akash R.B., Yallur B.C., Manjunatha D.H. (2025) Thiazoles: Synthesis, biological activities and their interaction studies with serum albumins. Total Chem., 1 100006. https://doi.org/10.1016/j.totche.2025.100006
11. Tratrat C., Haroun M., Tsolaki E., Petrou A., Gavalas A., Geronikaki A. (2021) Thiazole-based chalcone derivatives as potential anti-inflammatory agents: Biological evaluation and molecular modelling. Curr. Top. Med. Chem., 21(4) 257-268. https://doi.org/10.2174/1568026621999201214232458
12. Rydchuk P., Tymoshuk O., Oleksiv L., Chaban T., Matiychuk V. (2019) Voltammetric determination of Pt (IV) using 5-hydroxyimino-4-imino-1,3-thiazolidine-2-one. Methods Objects Chem. Anal., 14(3) 130-139. http://dx.doi.org/10.17721/moca.2019.130-139
13. Bhagwat S.K., Chobe S.S., Alavala R.R., Vora A., More R.A., Bobade V.D., Patil A.A., Pawar T.J., Hernández-Rosas F., Patil S.V. (2025) Benzothiazole-thiazole hybrids as broad-spectrum antimicrobial agents: synthesis, SAR analysis, and molecular docking against bacterial and fungal targets. RSC Adv., 15 31752-31762. https://doi.org/10.1039/D5RA04254B
14. Niu Z.-X., Wang Y.-T., Zhang S.-N., Li Y., Chen X.-B., Wang S.-Q., Liu H.-M. (2023) Application and synthesis of thiazole ring in clinically approved drugs. Eur. J. Med. Chem., 250 115172. https://doi.org/10.1016/j.ejmech.2023.115172
15. Chaban T.I., Matiichuk Y.E., Horishny V.Y., Chaban I.G., Matiychuk V.S. (2020) Synthesis and anticancer activity of 2-aryl-3-methylbenzofuro[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-dione and 2-aryl-3,7,9-trimethylpyrido[3',2':4,5]thieno[3,2-b]pyrazolo[4,3-e]azepine-4,11(2H,10H)-diones. Russ. J. Org. Chem., 56(5), 813-818. http://dx.doi.org/10.1134/S1070428020050139
16. Chugh V., Pandey G., Rautela R., Mohan C. (2022) Heterocyclic compounds containing thiazole ring as important material in medicinal chemistry. Mater. Today Proc., 69(2) 478-481. https://doi.org/10.1016/j.matpr.2022.09.150
17. Meanwell N.A. (2011) Synopsis of some recent tactical application of bioisosteres in drug design. J. Med. Chem., 54(8) 2529-2591. https://doi.org/10.1021/jm1013693
18. Brown D.G., Boström J. (2016) Analysis of past and present synthetic methodologies on medicinal chemistry: Where have all the new reactions gone? J. Med. Chem., 59(10) 4443-4458. https://doi.org/10.1021/acs.jmedchem.5b01409
19. Petrou A., Fesatidou M., Geronikaki A. (2021) Thiazole ring – A biologically active scaffold. Molesules, 26(11) 3166. https://doi.org/10.3390/molecules26113166
20. Gümüş M., Yakan M., Koca I. (2019) Recent advances of thiazole hybrids in biological applications. Future Med. Chem., 11(15) 1979-1998. https://doi.org/10.4155/fmc-2018-0196
21. Shahin I.G., Mohamed K.O., Taher A.T., Mayhoub A.S., Kassab A.E. (2023) Recent advances in the synthesis of thiazole ring: Mini review. Mini-Rev. Org. Chem., 20(3) 270-284. https://doi.org/10.2174/1570193X19666220413104255
22. Lelyukh M., Adamchuk S., Harkov S., Chaban I., Demchuk I., Shelepeten L., Chaban T. (2018) Synthetic approaches, chemical modification and biological activity of non-condensed 1,3,4-thiadiazole derivatives: A review. Pharmacia, 65(4) 72-88.
23. Minakshi, Kaswan P., Singh K., Devi, Singh R., Yadav N., Yadav M. (2025) Recent advances in di-, tri-substituted mono-thiazoles, and bis-thiazoles: Factors affecting biological activities, future aspects, and challenges. Curr. Top. Med. Chem., 25(23) 2681-2726. 10.2174/0115680266334873250316102556
24. Narasimhamurthy K.H., Swaroop T.R., Rangappa K.S. (2024) A review on progress of thiazole derivatives as potential anti-inflammatory agents. Reports, 12 100225. https://doi.org/10.1016/j.ejmcr.2024.100225
25. Klebe G. (2015) Applying thermodynamic profiling in lead finding and optimization. Nat. Rev. Drug Discov., 14 95-110. https://doi.org/10.1038/nrd4486
26. El-Shoukrofy M.S., Ismail A., Elhamammy R.H., Abdelhady S.A., Nassra R., Makkar M.S., Agami M.A., Wahid A., Nematalla H.A., Sai M., Merk D., El-Yazbi A.F., Belal A.S.F., Eid A.H., Elzahhar P.A. (2025) Novel thiazolones for the simultaneous modulation of PPARγ, COX-2 and 15-LOX to address metabolic disease-associated portal inflammation. Eur. J. Med. Chem., 289 117415. https://doi.org/10.1016/j.ejmech.2025.117415
27. Jacob J.P., Manju S.L. (2020) Identification and development of thiazole leads as COX-2/5-LOX inhibitors through in-vitro and in-vivo biological evaluation for anti-inflammatory activity. Bioorg. Chem., 100 103882. https://doi.org/10.1016/j.bioorg.2020.103882
28. Sinha S., Manju S.L., Doble M (2019) Chalcone-thiazole hybrids: Rational design, synthesis, and lead identification against 5-lipoxygenase. ACS Med. Chem., 10(10) 1415-1422. https://doi.org/10.1021/acsmedchemlett.9b00193
29. Hawash M., Jaradat N., Sabobeh R., Abualhasan M., Qaoud M.T. (2023) New thiazole carboxamide derivatives as COX inhibitors: Design, synthesis, anticancer screening, in silico molecular docking, and ADME profile studies. ACS Omega, 8(32) 29512-29526. https://doi.org/10.1021/acsomega.3c03256
30. Minhas R., Bansal Y., Bansal G. (2019) Inducible nitric oxide synthase inhibitors: A comprehensive update. Med. Res. Rev., 40(3) 823-855. https://doi.org/10.1002/med.21636
31. Seboletswe P., Cele N., Singh P. (2023) Thiazolidinone-heterocycle frameworks: A concise review of their pharmacological significance. ChemMedChem., 18(7) e20220618. https://doi.org/10.1002/cmdc.202200618
32. Сhulovska Z, Chaban T., Drapak I., Matiychuk V. Chaban I., Nektegaev I. (2021) Synthesis of some С5 substituted 4-phenylimino-thiazolidin-2-ones as possible anti-inflammatory agents. Biointerface Res. Appl. Chem., 11(1) 8009-8017. https://doi.org/10.33263/BRIAC111.80098017
33. Singh V., Jha K.T., Singh S., Singh R., Chawla P.A. (2025) Targeting inflammation through inhibition of COX-2 by substituted 4-thiazolidinone analogues: in-vitro, in-vivo and in-silico studies. J. Mol. Struct., 1319(1) 139393. https://doi.org/10.1016/j.molstruc.2024.139393
34. Mekhlef Y.O., AboulMagd A.M., Gouda A.M. (2023) Design, synthesis, molecular docking, and biological evaluation of novel 2,3-diaryl-1,3-thiazolidine-4-one derivatives as potential anti-inflammatory and cytotoxic agents. Bioorg. Chem., 133 106411. https://doi.org/10.1016/j.bioorg.2023.106411
35. Archna, Chawla P.A., Teli G., Pathania S., Singh S., Srivastava V. (2023) Exploration of antioxidant, anti-inflammatory and anticancer potential of substituted 4-thiazolidinone derivatives: Synthesis, biological evaluation and docking studies. Polycycl. Aromat. Compd., 43(1) 597-618. https://doi.org/10.1080/10406638.2021.2019796
36. Omar Y.M., Abdel-Moty S.G., Abdu-Allah H.H.M. (2020) Further insight into the dual COX-2 and 15-LOX anti-inlammatory activity of 1,3,4-thiadiazole-thiazolidinone hybrids: The contribution of the substituents at 5th positions is size dependent. Bioorg. Chem., 97 103657. https://doi.org/10.1016/j.bioorg.2020.103657
37. Liaras K., Fesatidou M., Geronikaki A. (2018) Thiazoles and thiazolidinones as COX/LOX inhibitors. Molecules, 23(3) 685. https://doi.org/10.3390/molecules23030685
38. Mech D., Kurowska A., Trotsko N. (2021) The bioactivity of thiazolidin-4-ones: A short review of the most recent studies. Int. J. Mol. Sci., 22(21) 11533. https://doi.org/10.3390/ijms222111533
39. Yadav K.P., Rahman MdA., Nishad S., Maurya S.K., Anas M., Mujahid M. (2023) Synthesis and biological activities of benzothiazole derivatives: A review. Intell. Pharm., 1(3) 122-132. https://doi.org/10.1016/j.ipha.2023.06.001
40. Islam MdR., Fahmy H. (2022) Thiazolopyrimidine scaffold as a promising nucleus for developing anticancer drugs: A review conducted in last decade. Anticancer Agents Med. Chem., 22(17) 2942-2955. https://doi.org/10.2174/1871520622666220411110528
41. Amrutkar V.S., Khator R., Monga V (2025) Recent progress in the synthetic and medicinal perspective of imidazo[2,1-b]thiazole derivatives. Future Med. Chem., 17(17) 2163-2177. https://doi.org/10.1080/17568919.2025.2552637
42. Keri R.S., Patil M.R., Patil S.A., Budagumpi S. (2015) A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry. Eur. J. Med. Chem., 89 207-251. https://doi.org/10.3897/10.1016/j.ejmech.2014.10.059
43. Mishra S., Arora N., Gupta S.K., Yogi B., Arora P. (2025) Recent advances in pyrazole and benzothiazole derivatives as potential anti-inflammatory agents: Synthesis, mechanisms, and therapeutic implication. Chem. Res. J., 10(3) 69-77.
44. Tan J., He Y., Lin U., Zhong Y., He S., Zuo J., Yang C. (2024) Synthesis of 2-amino-9H-chromeno[2,3-d]thiazol-9-ones with anti-inflammatory activity via cascade reactions of 2-amino-3 iodochromones with amines and carbon disulfide. RSC Adv., 14 3158-3162. https://doi.org/10.1039/D3RA07209F
45. Gupta K., Sirbaiya A.K., Kumar V., Rahman M.A. (2022) Current perspective of synthesis of medicinally relevant benzothiazole based molecules: Potential for antimicrobial and anti-inflammatory activities. Mini-Rev. Med. Chem., 22(14) 1895-1935. https://doi.org/10.2174/1389557522666220217101805
46. Chaban T., Matiychuk V., Komarytsya O., Myrko I., Chaban I., Ogurtsov V., Nektegaev I. (2020) Anti-inflammatory properties of some novel thiazolo[4,5-b]pyridin-2-ones. Pharmacia, 67(3) 121-127. https://doi.org/10.3897/pharmacia.67.e38969
47. Shahrasbi M., Mohaved M.A., Dadras O.G., Daraei B., Zarghi A. (2018) Design, synthesis and biological evaluation of new imidazo[2,1-b]thiazole derivatives as selective COX-2 inhibitors. Iran. J. Pharm. Res., 17(4) 1288-1296.
48. Bhagwat S.K., Chobe S.S., Alavala R.R., Vora A., More R.A., Bobade V.D., Patil A.A., Pawar T.J., Hernandez-Rosas F., Patil S.V. (2025) Benzothiazole–thiazole hybrids as broad-spectrum antimicrobial agents: Synthesis, SAR analysis, and molecular docking against bacterial and fungal targets. RSC Adv., 15 31752-31762. https://doi.org/10.1039/D5RA04254B
49. Alkorbi F., Alshareef S.A., Abdelaziz M.A., Omer N., Jame R., Alatawi I.S., Ali A.M., Omran O.A., Bakr R.B. (2025) Multicomponent reaction for synthesis, molecular docking, and anti-inflammatory evaluation of novel indole-thiazole hybrid derivatives. Mol. Divers., 29(5) 3945-3956. https://doi.org/10.1007/s11030-024-10969-8
50. Abdul-Malik M.A., El-Dean A.M.K., Hussein A.H.M., Abdelmonsef A.H., Tolba M.S. (2026) Synthesis, in silico and in vivo evaluation of new pyrazole-based thiosemicarbazones containing thiazole and thiazolone moieties as potential anti-inflammatory agents. J. Mol. Struct., 1350(1) 143990. https://doi.org/10.1016/j.molstruc.2025.143990
51. Ungureanu D., Marc G., Tiperciuc B., Moldovan C., Ionut I., Staba A., Oniga I., Vlase L., Pîrnău A., Oniga O. (2025) Novel 3,4-dihydroxyphenyl-thiazole-coumarin hybrid compounds: Synthesis, in silico and in vitro evaluation of their antioxidant activity. Antioxidants, 14(6) 636. https://doi.org/10.3390/antiox14060636
52. Cancela S., Minini L., Mourglia-Ettlin G., Merlino A., Lavaggi M.L., Hernandez P. (2025) Novel thiazole-nitrone hybrids as innovative neuroprotective agents with antioxidant and antiapoptotic properties. Results Chem., 16 102414. https://doi.org/10.1016/j.rechem.2025.102414
53. Hegazy M.E., Taher E.S., Ghiaty A.H., Bayoumi A.H. (2024) Tailored quinoline hybrids as promising COX-2/15-LOX dual inhibitors endowed with diverse safety profile: Design, synthesis, SAR, and histopathological study. Biorg. Chem., 145 107244. https://doi.org/10.1016/j.bioorg.2024.107244
54. Maghraby M.T.-E., Abou-Ghadir O.M.F., Abdel-Moty S.G., Ali A.Y., Salem O.I.A. (2020) Novel class of benzimidazole-thiazole hybrids: The privileged scaffolds of potent anti-inflammatory activity with dual inhibition of cyclooxygenase and 15-lipoxygenase enzymes. Bioorg. Med. Chem., 28(7) 115403. https://doi.org/10.1016/j.bmc.2020.115403
55. Di L., Kerns E.H. (2003) Profiling drug-like properties in discovery research. Curr. Opin. Chem. Biol., 7(3) 402-408. https://doi.org/10.1016/S1367-5931(03)00055-3
56. Khanapure S.P., Garvey D.S., Janero D.R., Letts L.G. (2007) Eicosanoids in inflammation: Biosynthesis, pharmacology, and therapeutic frontiers. Curr. Top. Med. Chem., 7(3) 311-340. https://doi.org/10.2174/156802607779941314
57. Hawash M., Jaradat N., Abualhasan M., Şüküroğlu M.K., Qaoud M.T., Kahraman D.C., Daraghmeh H., Maslamani L., Sawafta M., Ratrout A., Issa L. (2023) Design, synthesis, molecular docking studies and biological evaluation of thiazole carboxamide derivatives as COX inhibitors. BMC Chem., 17(1) 11. https://doi.org/10.1186/s13065-023-00924-3
58. Mohammed E.R., Abd-El-Fatah A.H., Mohamed A.R., Mahrouse M.A., Mohammad M.A. (2024) Discovery of new 2-(3-(naphthalen-2-yl)-4,5-dihydro-1H-pyrazol-1-yl)thiazole derivatives with potential analgesic and anti-inflammatory activities: In vitro, in vivo and in silico investigations. Bioorg. Chem., 147 107372. https://doi.org/10.1016/j.bioorg.2024.107372
59. Sinha S., Sravanthi T.V., Yuvaraj S., Manju S.L., Doble M. (2016) 2-Amino-4-aryl thiazole: A promising scaffold identified as a potent 5-LOX inhibitor. RSC Adv., 6(13) 19271-19279. https://doi.org/10.1039/C5RA28187C
60. Agrawal N. (2025) A comprehensive review on the advancements of dual COX-2/5-LOX inhibitors as anti-inflammatory drugs. Chem. Biol. Drug. Des., 105(5) e70114. https://doi.org/10.1111/cbdd.70114
61. Abdulaziz O., Alsuwat M.A., Jan M.S., Sadiq A. (2024) Modification of 4-(4-chlorothiophen-2-yl)thiazol-2-amine derivatives for the treatment of analgesia and inflammation: Synthesis and in vitro, in vivo, and in silico studies. Front. Pharmacol., 15 1366695. https://doi.org/10.3389/fphar.2024.1366695
62. Vasu K.K., Digwal C.S., Pandya A.N., Pandya D.H., Sharma J.A., Patel S., Agarwal M. (2017) Imidazo[1,2-a]pyridines linked with thiazoles/thiophene motif through keto spacer as potential cytotoxic agents and NF-κB inhibitors. Bioorg. Med. Chem. Lett., 27(24) 5463-5466. https://doi.org/10.1016/j.bmcl.2017.10.060
63. Üremiş M.M., Üremiş N., Ceylan M., Türköz Y. (2025) Anticancer and anti-inflammatory effects of benzothiazole derivatives targeting NF-κB/COX-2/iNOS in a hepatocellular carcinoma cell line. Turk. J. Pharm. Sci., 22(3) 207-216. https://doi.org/10.4274/tjps.galenos.2025.49840
64. Tariq S., Alam O., Amir M. (2018) Synthesis, p38α MAP kinase inhibition, anti-inflammatory activity, and molecular docking studies of 1,2,4-triazole-based benzothiazole-2-amines. Arch. Pharm., 351(3-4) 1700304. https://doi.org/10.1002/ardp.201700304
65. Ebaid M.S., Ibrahim H.A.A., Kassem A.F., Sabt A. (2024) Recent studies on protein kinase signaling inhibitors based on thiazoles: Review to date. RSC Adv., 14(50) 36989-37018. https://doi.org/10.1039/d4ra05601a
66. Ge L., Hu Q., Shi M., Yang H., Zhu G. (2017) Design and discovery of novel thiazole derivatives as potential MMP inhibitors to protect against acute lung injury in sepsis rats via attenuation of inflammation and apoptotic oxidative stress. RSC Adv., 7 32909-32922. https://doi.org/10.1039/C7RA03511J
67. Malik Z., Abbas M., Al Kury L.T., Shah F.A., Alam M., Khan A.-U., Nadeem H., Alghamdi S., Sahibzada M.U.K., Li S. (2021) Thiazolidine derivatives attenuate carrageenan-induced inflammatory pain in mice. Drug Des. Devel. Ther., 15 369-384. https://doi.org/10.2147/DDDT.S281559
68. Sung M., Lim S., Park S., Choi Y., Kom S. (2024) Anti-inflammatory effects of phytosphingosine-regulated cytokines and NF-kB and MAPK mechanism. Cell. Mol. Biol., 70(9) 22-30. https://doi.org/10.14715/cmb/2024.70.9.3
69. Filho C.A.L.M., de Oliveira Barbosa M., Oliveira A.R., Pinto A.F., Araújo D.L., Lucena J.P., de Araújo R.E., de Oliveira S.A., Leite A.C.L. (2022) The prophylactic and anti-fibrotic activity of phthalimido-thiazole derivatives in schistosomiasis mansoni. Parasitol Res., 121(7) 2111-2120. https://doi.org/10.1007/s00436-022-07533-4
70. Feng X., Yu W., Cao L., Meng F., Cong M. (2020) A novel chrysin thiazole derivative polarizes macrophages to an M1 phenotype via targeting TLR4. Int. Immunopharmacol., 88 106986. https://doi.org/10.1016/j.intimp.2020.106986
71. Manful C.F., Fordjour E., Ikumoinein E., Abbey L., Thomas R. (2025) Therapeutic strategies targeting oxidative stress and inflammation: A narrative review. BioChem., 5(4) 35. https://doi.org/10.3390/biochem5040035
72. Marc G., Stana A., Franchini A.H., Vodnar D.C., Barta G., Tertis M., Santa I., Cristea C., Pîrnău A., Ciorîţă A., Dume B., Toma V.-A., Vlase L., Oniga I., Oniga O. (2021) Phenolic thiazoles with antioxidant and antiradical activity. Synthesis, in vitro evaluation, toxicity, electrochemical behavior, quantum studies and antimicrobial screening. Antioxidants, 10(11) 1707. https://doi.org/10.3390/antiox10111707
73. Shalai Ya.R., Popovych M.V., Mandzynets S.M., Hreniukh V.P., Finiuk N.S., Babsky A.M. (2021) Prooxidant and antioxidant processes in the liver homogenate of healthy and tumor-bearing mice under the action of thiazole derivatives. Ukr. Biochem. J., 93(3) 61-67. doi: https://doi.org/10.15407/ubj93.03.061
74. Korkmaz I.N. (2024) Investigation of the effects of thiazole compounds on thioredoxin reductase 1 (TrxR1), glutathione S-transferase (GST), and glutathione reductase (GR) targeted human brain glioblastoma cancer (U-87 MG). Biotechnol. Appl. Biochem., 71(4) 948-959. https://doi.org/10.1002/bab.2589
75. Zhong R., Miao L., Zhang H., Tan L., Zhao Y., Tu Y., Prieto A., Simal-Gandara J., Chen L., He C., Cao H. (2022) Anti-inflammatory activity of flavonols via inhibiting MAPK and NF-κB signaling pathways in RAW264.7 macrophages. Curr. Res. Food Sci., 5 1176-1184. https://doi.org/10.1016/j.crfs.2022.07.007
76. Raut D.G., Bhosale R.B., Lawand A.S., Hublikar M.G., Kadu V.D., Patil S.B., Choudhari P.B. (2022) Syntheses, molecular docking and biological evaluation of 2-(2-hydrazinyl)thiazoles as potential antioxidant, anti-inflammatory and significant anticancer agents. Recent Pat. Inflamm. Allergy. Drug Discov., 16(2) 96-106. https://doi.org/10.2174/2772270816666220902094019
77. Smelcerovic A., Zivkovic A., Ilic B.S., Kolarevic A., Hofmann B., Steinhilber D., Stark H. (2020) 4-(4-Chlorophenyl)thiazol-2-amines as pioneers of potential neurodegenerative therapeutics with anti-inflammatory properties based on dual DNase I and 5-LO inhibition. Bioorg. Chem., 95 103528. https://doi.org/10.1016/j.bioorg.2019.103528
78. Sağlık B.N., Osmaniye D., Levent S., Çevik U.A., Çavuşoğlu B.K., Yusuf Özkay Y., Kaplancikli Z.A. (2021) Design, synthesis and biological assessment of new selective COX-2 inhibitors including methyl sulfonyl moiety. Eur. J. Med. Chem., 209 112918. https://doi.org/10.1016/j.ejmech.2020.112918
79. Fadaly W.A.A., Zidan T.H., Kahk N.M., Mohamed F.E.A., Abdelhakeem M.M., Khalil R.G., Nemr M..M. (2023) New pyrazolyl-thiazolidinone/thiazole derivatives as celecoxib/dasatinib analogues with selective COX-2, HER-2 and EGFR inhibitory effects: Design, synthesis, anti-inflammatory/anti-proliferative activities, apoptosis, molecular modelling and ADME studies. J. Enzyme Inhib. Med. Chem., 38(1) 2281262. https://doi.org/10.1080/14756366.2023.2281262
80. Irmak N.E., Saglik B.N., Celik I., Sen H.T., Ozkay Y., Ayhan-Kilcigil G. (2023) Design, synthesis, molecular docking and molecular dynamic studies of novel benzimidazole–thiazole derivatives as potent and selective COX-2 inhibitors. New J. Chem., 47 21620-21632. https://doi.org/10.1039/D3NJ04438F
81. Jaismy J.P., Manju S.L. (2021) Novel approach of multi-targeted thiazoles and thiazolidenes toward anti-inflammatory and anticancer therapy – dual inhibition of COX-2 and 5-LOX enzymes. Med. Chem. Res., 30 236-257. https://doi.org/10.1007/s00044-020-02655-9
82. Elgohary M.K., Abd El Hadi S.R., Abo-Ashour M.F., Abo-El Fetoh M.E., Afify H., Abdel-Aziz H.A., Abou-Seri S.M. (2023) Fragment merging approach for the design of thiazole/thiazolidine clubbed pyrazoline derivatives as anti-inflammatory agents: Synthesis, biopharmacological evaluation and molecular modeling studies. Bioorg. Chem., 139 106724. https://doi.org/10.1016/j.bioorg.2023.106724
83. El-Miligy M.M.M., Al-Kubeisi A.K., Nassra R.A., El-Zemity S.R., Hazzaa A.A. (2024) Discovery of new thymol-3,4-disubstituted thiazole hybrids as dual COX-2/5-LOX inhibitors with in vivo proof. J. Enzyme Inhib. Med. Chem., 39(1) 2309171. https://doi.org/10.1080/14756366.2024.2309171
84. Kim M.E., Le J.S. (2025) Advances in the regulation of inflammatory mediators in nitric oxide synthase: Implications for disease modulation and therapeutic approaches. Int. J. Mol. Sci., 26(3) 1204. https://doi.org/10.3390/ijms26031204
85. Khanh N.D., Anh N.T.H., Son N.V., Tho N.T.M., Yhang N.T.N., Quyen T.T., An T.N.M. (2026) Design, synthesis, biological evaluation, and in silico studies of novel 1,3-thiazole derivatives. RSC Adv., 16 2342. https://doi.org/10.1039/D5RA08472E
86. Fang S., Huang X., Cai F., Qiu G., Lin F., Cai X. (2024) Design, synthesis and molecular docking of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazole derivatives that act as iNOS/COX-2 inhibitors with potent anti-inflammatory activity against LPS-induced RAW264.7 macrophage cells. J. Steroid Biochem. Mol. Biol., 240 106478. https://doi.org/10.1016/j.jsbmb.2024.106478
87. Facchin B.M., Dos Reis G.O., Vieira G.N., Mohr E.T.B., da Rosa J.S., Kretzer I.F., Demarchi I.G., Dalmarco E.M. (2022) Inflammatory biomarkers on an LPS-induced RAW 264.7 cell model: A systematic review and meta-analysis. Inflamm. Res., 71(7-8) 741-758. https://doi.org/10.1007/s00011-022-01584-0
88. Ganie M.A., Ansari S.M., Choudhary R., Fayaz F., Kour G., Gupta V., Ahmed Z., Javed S., Shah B.A. (2024) Investigation of an aminothiazole-based scaffold as an anti-inflammatory agent: Potential application in the management of cytokine storm in SARS-CoV-19. J. Mol. Struct., 1303 137562. https://doi.org/10.1016/j.molstruc.2024.137562
89. Efeoglu C., Taskin S., Selcuk O., Celik B., Tumkaya E., Ece A., Sari H., Seferoglu Z., Ayaz F., Nural Y. (2023) Synthesis, anti-inflammatory activity, inverse molecular docking, and acid dissociation constants of new naphthoquinone-thiazole hybrids. Bioorg. Med. Chem., 95 117510. https://doi.org/10.1016/j.bmc.2023.117510
90. Xu X., Zhu Z., Chen S., Fu Y., Zhang J., Guo Y., Xu Z., Xi Y., Wang X., Ye F., Chen H., and Yang X. (2024) Synthesis and biological evaluation of novel benzothiazole derivatives as potential anticancer and antiinflammatory agents. Front. Chem., 12 1384301. https://doi.org/10.3389/fchem.2024.1384301
91. Fang T., Eglen R.M. (2017) Three-dimensional cell cultures in drug discovery and development. SLAS Discov., 22(5) 456-472. https://doi.org/10.1177/1087057117696795
92. Rumpf J., Burger R., Schulze M. (2023) Statistical evaluation of DPPH, ABTS, FRAP, and Folin-Ciocalteu assays to assess the antioxidant capacity of lignins. Int. J. Biol. Macromol., 233 123470. https://doi.org/10.1016/j.ijbiomac.2023.123470
93. Bansal A., Bali A., Balaini A. (2020) Synthesis and evaluation of substituted aryl thiazoles with antioxidant potential as gastro-sparing anti-inflammatory agents. Lett. Drug Des. Discov., 17(12) 1566-1578. https://doi.org/10.2174/1570180817999200706005247
94. Patil S.M., Kamble O., Asgaonkar K., Bhandari S., Chitre T., Rathod V., Bhosale P., Gavali P., Das A. (2026) Design and development of pyrazole–thiazole hybrid derivatives as anti-inflammatory and anti-oxidant agents. J. Mol. Struct., 1353(2) 144688. https://doi.org/10.1016/j.molstruc.2025.144688
95. Eruslanov E., Kusmartsev S. (2010) Identification of ROS using oxidized DCFDA and flow-cytometry. Methods Mol. Biol., 594 57-72. https://doi.org/10.1007/978-1-60761-411-1_4
96. Leng S.X., McElhaney J.E., Walston J.D., Xie D., Fedarko N.S., Kuchel G.A. (2008) ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A Biol. Sci. Med. Sci., 63(8) 879-884. https://doi.org/10.1093/gerona/63.8.879
97. Liou C.-J., Len W.-B., Wu S.-J., Lin C.-F., Wu X.-L., Huang W.-C. (2014) Casticin inhibits COX-2 and iNOS expression via suppression of NF-κB and MAPK signaling in lipopolysaccharide-stimulated mouse macrophages. J. Ethnopharmacol., 158 310-316. https://doi.org/10.1016/j.jep.2014.10.046
98. Yan Z., Wang Y., Song Y., Ma Y., An Y., Wen R., Wang N., Huang Y., Wu X. (2023) Phenethylferulate as a natural inhibitor of inflammation in LPS-stimulated RAW 264.7 macrophages: Focus on NF-κB, Akt and MAPK signaling pathways. BMC Complement Med. Ther., 23 398. https://doi.org/10.1186/s12906-023-04234-y
99. Yue L., Luo J., Zhao C., Zhao J., Ye J., He K., Zou J. (2024) Oleanane triterpenoids with C-14 carboxyl group from Astilbe grandis inhibited LPS-induced macrophages activation by suppressing the NF-κB signaling pathway. Front. Pharmacol., 15 1413876. https://doi.org/10.3389/fphar.2024.1413876
100. Dahlin J.L., Walters M.A. (2014) The essential roles of chemistry in high-throughput screening triage. Future Med. Chem., 6(11) 1265-1290. https://doi.org/10.4155/fmc.14.60
101. Zhang Z., Cao P., Fang M., Zou T., Han J., Duan Y., Xu H., Yang X., Li Q.-S. (2021) Design, synthesis, and SAR study of novel 4,5-dihydropyrazole-thiazole derivatives with anti-inflammatory activities for the treatment of sepsis. Eur. J. Med. Chem., 225 113743. https://doi.org/10.1016/j.ejmech.2021.113743
102. Raut D.G., Lawand A.S., Kadu V.D., Hublikar M.G., Patil S.B., Bhosale D.G., Bhosale R.B. (2022) Synthesis of asymmetric thiazolyl pyrazolines as a potential antioxidant and anti-inflammatory agents. Polycycl. Aromat. Compd., 42(1) 70-79. https://doi.org/10.1080/10406638.2020.1716028
103. Hussain F., Tahir A., Rehman H.M., Wu Y., Shah M., Rashid U. (2025) Promising thiazolidinedione-thiazole based multi-target and neuroprotective hybrids for Alzheimer's disease: Design, synthesis, in-vitro, in-vivo and in-silico studies. Eur. J. Med. Chem., 287 117327. https://doi.org/10.1016/j.ejmech.2025.117327
104. Stella V.J., Nti-Addae K.W. (2007) Prodrug strategies to overcome poor water solubility. Adv. Drug Deliv. Rev., 59(7) 677-694. https://doi.org/10.1016/j.addr.2007.05.013
105. Lillethorup I.A., Hemmingsen A.V., Qvortrup K. (2025) Prodrugs and their activation mechanisms for brain drug delivery. RSC Med. Chem., 16 1037-1048. https://doi.org/10.1039/D4MD00788C
106. Islam S., Ahmed MdM.S., Islam M.A., Hossain N., Chowdhury M.A. (2025) Advances in nanoparticles in targeted drug delivery – A review. Results Surf. Interfaces, 19 100529. https://doi.org/10.1016/j.rsurfi.2025.100529
107. Hegde M., Mishra A., Banerjee R., Bintee B., Alqahtani M.S., Abbas M., Shanmugam M.K., Drum C.L., Setgi G., Liu L., Kunnumakkara A.B. (2025) Bioresponsive engineered nanoparticles for immunomodulation. BMC Med, 23 595. https://doi.org/10.1186/s12916-025-04305-6
108. Kumar G., Singh N.P. (2021) Synthesis, anti-inflammatory and analgesic evaluation of thiazole/oxazole substituted benzothiazole derivatives. Bioorg. Chem., 107 104608. https://doi.org/10.1016/j.bioorg.2020.104608
109. Abdel-Aziz S.A., Taher E.S., Lan P., El-Koussi N.A., Salem O.I.A., Gomaa H.A.M., Youssif B.G.M. (2022) New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition. Arch. Pharm., 355(7) 2200024. https://doi.org/10.1002/ardp.202200024
110. Khan S., Chinnam S., Iqbal T., Hussain R., Ur Rehman M., Khan Y., Iqbal J., Dera A.A. (2025) A novel class of thiazole based thiadiazole hybrids: The privileged scaffolds of potent anti-Alzheimer's activity along with molecular docking and ADME analysis. J. Mol. Struct., 1321(1) 139775. https://doi.org/10.1016/j.molstruc.2024.139775
111. Cai X., Cai J., Fang L., Xu S., Zhu H., Wu S., Chen Y., Fang S. (2024) Design, synthesis and molecular modeling of novel D-ring substituted steroidal 4,5-dihydropyrazole thiazolinone derivatives as anti-inflammatory agents by inhibition of COX-2/iNOS production and down-regulation of NF-κB/MAPKs in LPS-induced RAW264.7 macrophage cells. Eur. J. Med. Chem., 272 116460. https://doi.org/10.1016/j.ejmech.2024.116460
112. Cai N., Gao X., Yang L., Li W., Sun W., Zhang S., Zhao J., Qu J., Zhou Y. (2024) Discovery of novel NSAID hybrids as cPLA2/COX-2 dual inhibitors alleviating rheumatoid arthritis via inhibiting p38 MAPK pathway. Eur. J. Med. Chem., 267 116176. https://doi.org/10.1016/j.ejmech.2024.116176
113. Kumari L., Choudhari Y., Patel P., Gupta G.D., Singh D., Rosenholm J.M., Bansal K.K., Kurmi B.D. (2023) Advancement in solubilization approaches: A step towards bioavailability enhancement of poorly soluble drugs. Life, 13(5) 1099. https://doi.org/10.3390/life13051099
114. Du J., Li X., Zhao H., Zhou Y., Wang L., Tian S., Wang Y. (2015) Nanosuspensions of poorly water-soluble drugs prepared by bottom-up technologies. Int. J. Pharm., 495(2) 738-749. https://doi.org/10.1016/j.ijpharm.2015.09.021
115. Arnott J.A., Planey S.L. (2012) The influence of lipophilicity in drug discovery and design. Expert Opin. Drug Discov., 7(10) 863-875. https://doi.org/10.1517/17460441.2012.714363
116. Gajula S.N.R., Nadimpalli N., Sonti R. (2021) Drug metabolic stability in early drug discovery to develop potential lead compounds. Drug Metab. Rev., 53(3) 459-477. https://doi.org/10.1080/03602532.2021.1970178
117. Meanwell N.A. (2014) The influence of bioisosteres in drug design: Tactical applications to address developability problems. Tactics Contemp. Drug Des., 9 283-381. https://doi.org/10.1007/7355_2013_29
118. Bukke S.P.N., Venkatesh C., Rajanna S.B., Saraswathi T.S., Kusuma P.K., Goruntla N., Balasuramanyam N., Munishamireddy S. (2024) Solid lipid nanocarriers for drug delivery: design innovations and characterization strategies – a comprehensive review. Discov. Appl. Sci., 6 279. https://doi.org/10.1007/s42452-024-05897-z